3rd Quarter - Report

AMERICAN SOCIETY OF HEALTH-SYSTEM PHARMACISTS for AMERICAN SOCIETY OF HEALTH-SYSTEM PHARMACISTS

Firm
Client
Income
—
Expenses
$250,000
Expense method
A: Lobbying Disclosure Act definitions

What was lobbied

3 issue areas, each in the filer's own words, with who lobbied on it and where.

Health Issues HCR

H.R. 2642, Iraq War Supplemental Appropriations, support additional appropriations for Food and Drug Administration. Communications to FDA staff regarding gluten labeling on medications; Risk Communication Advisory Committee meeting; maintaining HFA designation on labeling. Meeting with FDA Chief of Staff; Communication to FDA re: testimony before joint meeting of the Antiviral Drugs Advisory Committee and the Nonprescription Drugs Advisory Committee; Comments to FDA re concept paper on evaluating proposed drug name submissions. Comments to FDA on content and format labeling for human prescription drug and biological products; requirements for pregnancy and lactation labeling; Communication re; nominations to FDA advisory committee

LobbyistCovered position, as disclosed
JUSTINE COFFEY —
MORGAN HANSON New —
JOSEPH M HILL —
BRIAN M MEYER —
GERALYN TRUJILLO —

Contacted: Centers For Medicare and Medicaid Services (CMS); Drug Enforcement Administration (DEA); SENATE; Health & Human Services, Dept of (HHS); HOUSE OF REPRESENTATIVES; Food & Drug Administration (FDA)

Bills named: H.R. 2642 (110th)

Medicare/Medicaid MMM

H.R. 6331, Medicare Improvements for Patients and Providers Act of 2008, Title I Section 182, provision that revises definition of medically accepted indication for drugs and conflicts of interest. Communication and meetings with CMS staff regarding compendia recognition. Presentation and written testimony before CMS' Ambulatory Payment Classification Panel regarding pharmacy overhead Comments to CMS re: Hospital Outpatient Prospective Payment System and 2009 Payment rates. Communications with CMS re: Conditions of Participation and Interpretive Guidance regarding standing orders and protocols. Comments to CMS re: e-prescribing exemption for computer generated facsimile transmissions.

LobbyistCovered position, as disclosed
JUSTINE COFFEY —
MORGAN HANSON New —
JOSEPH M HILL —
BRIAN M MEYER —
GERALYN TRUJILLO —

Contacted: SENATE; Centers For Medicare and Medicaid Services (CMS); Food & Drug Administration (FDA); Health & Human Services, Dept of (HHS); HOUSE OF REPRESENTATIVES; Drug Enforcement Administration (DEA)

Bills named: H.R. 6331 (110th)

Pharmacy PHA

S. 901, Health Centers Renewal Act of 2007, include pharmacists as eligible for loan forgiveness programs of the National Health Service Corps. S.2708, Caring for an Aging America Act of 2008, include pharmacists in geriatric training program. Proposed legislation to create an academic counterdetailing program on prescription drugs. Outlined potential role of the pahrmacist. S. 2932, Poison Center Support, Enhancement, and Awareness of 2008, support all provisions. H.R. 5491, The Pharmacy Technician Training and Registration Act of 2008; all provisions. FDA: Communicated policy concerning National Drug Code number system and need for improvements. DEA: proposed rule concerning electronic prescriptions for controlled substances. Comments to the Office of the Natinal Coordinator for Health Information Technology re: Draft Medication Gaps and Draft Order Sets.

LobbyistCovered position, as disclosed
JUSTINE COFFEY —
MORGAN HANSON New —
JOSEPH M HILL —
BRIAN M MEYER —
GERALYN TRUJILLO —

Contacted: Food & Drug Administration (FDA); Centers For Medicare and Medicaid Services (CMS); Health & Human Services, Dept of (HHS); Drug Enforcement Administration (DEA); SENATE; HOUSE OF REPRESENTATIVES

Bills named: S. 2708 (110th), S. 901 (110th), S. 2932 (110th), H.R. 5491 (110th)

Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.